- Home
- ATS vs EWTX Comparison
ATS vs EWTX Comparison
Compare ATS & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATS
- EWTX
- Stock Information
- Founded
- ATS 1978
- EWTX 2017
- Country
- ATS Canada
- EWTX United States
- Employees
- ATS N/A
- EWTX N/A
- Industry
- ATS
- EWTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATS
- EWTX Health Care
- Exchange
- ATS Nasdaq
- EWTX Nasdaq
- Market Cap
- ATS 2.8B
- EWTX 2.8B
- IPO Year
- ATS 2023
- EWTX 2021
- Fundamental
- Price
- ATS $30.39
- EWTX $35.51
- Analyst Decision
- ATS Sell
- EWTX Strong Buy
- Analyst Count
- ATS 2
- EWTX 5
- Target Price
- ATS $30.50
- EWTX $37.60
- AVG Volume (30 Days)
- ATS 123.5K
- EWTX 1.3M
- Earning Date
- ATS 01-01-0001
- EWTX 11-07-2024
- Dividend Yield
- ATS N/A
- EWTX N/A
- EPS Growth
- ATS 25.09
- EWTX N/A
- EPS
- ATS 1.34
- EWTX N/A
- Revenue
- ATS $2,172,581,741.00
- EWTX N/A
- Revenue This Year
- ATS N/A
- EWTX N/A
- Revenue Next Year
- ATS $8.27
- EWTX N/A
- P/E Ratio
- ATS $22.69
- EWTX N/A
- Revenue Growth
- ATS 9.30
- EWTX N/A
- 52 Week Low
- ATS $24.82
- EWTX $5.12
- 52 Week High
- ATS $44.70
- EWTX $36.66
- Technical
- Relative Strength Index (RSI)
- ATS 60.44
- EWTX 79.40
- Support Level
- ATS $28.80
- EWTX $31.33
- Resistance Level
- ATS $31.00
- EWTX $28.56
- Average True Range (ATR)
- ATS 0.70
- EWTX 1.66
- MACD
- ATS 0.06
- EWTX 0.54
- Stochastic Oscillator
- ATS 74.26
- EWTX 89.35
About ATS ATS Corporation
ATS Corp is a Canada-based company that provides automation systems. The company designs and builds customized automated manufacturing and testing systems for customers, and provides pre- and post-automation services. The company's products comprise conveyor systems, automated electrified monorails, tray handlers, laser systems, and other hardware and software products. The company also provides pre-automation solutions, including strategic direction and planning services, as well as aftermarket support. The company's clients come from the life sciences, food and beverage transportation, consumer products and electronics, and energy sectors. The company generates the majority of its sales from the North American and European markets.
About EWTX Edgewise Therapeutics Inc.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.